AUSTIN (WBAP/KLIF) – The State of Texas is not seeing a drop in demand for COVID-19 vaccine following the pause of the Johnson and Johnson COVID shot.
As a matter of fact, State Infectious Disease Expert Imelda Garcia says demand is still great especially with the increased availability of doses.
“More small providers, like pharmacies and doctors’ offices, have received vaccine over the last few weeks so if you don’t want to go to a mass vaccination site or get on a long waiting list, there are more options for you,” Dr. Garcia said.
In fact, two million more Texans have gotten at last one shot of vaccine in the past week.
Chief State Epidemiologist Jennifer Shuford does have guidance for people who received the Johnson and Johnson vaccine and are worried after exceedingly rare blood clotting was linked to the vaccine which resulted in a recommended pause nationwide.
“Anyone who got this vaccine monitor themselves and watch for symptoms that may occur,” Shuford said.
Specifically, a severe headache, leg or abdominal pain, or shortness of breath that comes within three weeks of getting the J&J single dose shot.
The state is not seeing a drop in demand of Pfizer or Moderna in the aftermath of the Johnson and Johnson pause.
Of the rare blood-clotting cases, none has been reported so far in Texas.
(Copyright 2021, WBAP/KLIF. All Rights Reserved.)
